Dr. Mitesh Kumar Dwivedi has completed PhD from Department of Biochemistry, The M. S. University of Baroda, Vadodara (2013); M.Sc. Microbiology from University of Mysore (2006) and B.Sc. Microbiology from Sardar Patel University (2004). Since 2014, he is serving as Assistant Professor at C. G. Bhakta Institute of Biotechnology, Uka Tarsadia University. He has published 42 research papers in reputed journals and written 5 book chapters. His research interests include exploring the immunological, genetic causes and therapeutics for autoimmune diseases such as Vitiligo, rheumatoid arthritis, thyroidism, etc. and use of probiotics in human health and diseases. N. Amaresan is a microbiologist and Professor at the Saveetha Institute of Basic Medical Sciences, Saveetha University, Chennai. He was previously an Assistant Professor at C.G. Bhakta Institute of Biotechnology, Uka Tarsadia University, Gujarat. He earned his PhD on endophytic plant growth-promoting bacteria from Bharathidasan University, Tamil Nadu. With extensive experience in teaching and research, he has made a number of original contributions across several allied fields of microbiology, principally plant–microbe interactions, bioremediation, and plant pathology. For his discoveries on agriculturally important microorganisms, he has received young scientist awards from the Association of Microbiologists of India and the National Academy of Biological Sciences, along with a visiting scientist fellowship from the National Academy of Sciences, India, to pursue advanced techniques. He has deposited more than 380 bacterial 16S rDNA and fungal ITS rDNA sequences in GenBank (NCBI, EMBL, and DDBJ) and preserved over 150 microbial germplasm accessions in culture collection centers across India. Dr. A. Sankaranarayanan is working as an Assistant Professor in Microbiology, C.G. Bhakta Institute of Biotechnology, Uka Tarsadia University, Gujarat from 2015 onwards. Prior to his present position he served as an Assistant Professor & Head, Department of Microbiology, K.S.R. College of Arts & Science, Tiruchengode, Tamil Nadu from 2002-2015. He has experience in the fields of antimicrobial activity, antibacterial potential of nanoparticles and environmental microbiology. His current research focus is on antibacterial potential of herbal products against multi drug resistant microbial pathogens and pesticide / insecticide degradation by bacteria and fungi in freshwater ecosystem. Dr Helen Kemp completed her PhD in Microbiology at the University of Warwick and the Centre for Applied Microbiology and Research, Salisbury, in 1988. Since 1989, she has worked at the University of Sheffield as a Postdoctoral Research Fellow in the Department of Molecular Biology and Biotechnology and then in the Department of Oncology and Metabolism. She has a long-standing interest in the autoimmune and genetic aspects of the depigmenting disease vitiligo and has international collaborations on projects to profile autoantibody responses against melanocytes in melanoma, vitiligo and alopecia areata. She is also interested in characterizing autoimmune responses against the calcium-sensing receptor in patients with parathyroid autoimmunity. She has published more than 70 research papers and has contributed to books and review articles. She has been on the British Skin Foundation Grant Review Board and served as Section Editor for the British Journal of Dermatology.

"Overall, the book provides a comprehensive review of the role of probiotics in human disease. Additionally, it moves the conversation toward their use in prevention and cure. There are very limited existing textbooks like this on the market, aside from a recently published title, Probiotics for Human Nutrition in Health and Disease, de Souza et al. (Elsevier, 2022), making comparison difficult. I noted grammatical errors and inconsistencies across sections, likely because a different group of researchers authored each chapter. If readers are able to overlook these details, this book proves itself a useful guide to improve the understanding of the present and possible future applications of probiotics. " --© Doody’s Review Service, 2021, Kristen Kimble, MS, RD, LDN, reviewer, expert opinion

• 1. The concept of probiotics, prebiotics, postbiotics, synbiotics, nutribiotics and pharmabiotics2. Food or Pharma: The name does make a difference3. The Role of Probiotics in maintaining immune homeostasis4. Probiotics in the prevention and management of Inflammatory bowel diseases (Crohn’s disease, Ulcerative colitis, Pouchitis)5. Probiotics in the prevention and management of Irritable bowel syndrome and Necrotising enterocolitis6. Probiotics in the prevention and treatment of Diarrhoeal Diseases7. Probiotics in the prevention and treatment of Atopic skin diseases (Atopic Dermatitis; Atopic eczema)8. Probiotics for the treatment of other dermatological conditions (acne, psoriasis, seborrheic dermatitis, wounds, and skin cancer)9. Probiotics in the prevention and management of allergic diseases (Asthma, Allergic Rhinitis)10. Prenatal and Neonatal Probiotic Intake in Pediatric Allergy11. Probiotics and Prebiotics in suppression of Autoimmune diseases (Cystic fibrosis, Rheumatoid arthritis)12. Probiotics and Prebiotics in the prevention and management of  Human cancers (Colon Cancer, Stomach cancer, Breast cancer, Cervix cancer) 13. Probiotics in mitigation of Food allergies and lactose intolerance14. Probiotics in the prevention and management of nosocomial infections15. Role of probiotics in Urological Health16. Role of probiotics in Prevention and treatment of Candida Vaginosis and Bacterial Vaginosis17. Role of Probiotics in Oral Healthcare (Dental Caries; Periodontal Diseases: Gingivitis and periodontitis, Halitosis)18. Role of probiotics in infections with Multidrug-Resistant Organisms (MDROs)19. Probiotics in the prevention and treatment of infections with Helicobacter pylori, Enterohemorrhagic E. coli and Rotavirus20. Role of Probiotics in management of Fungal infections21. Role of probiotics in the prevention and management of diabetics and obesity22. Probiotics in the prevention and management of cardiovascular diseases with focus on dyslipidemia23. Gut brain Axis: Role of probiotics in Neurological and neurodevelopmental disorders including Autism Spectrum Disorder24. Probiotics in prevention and control of food-borne diseases in humans25. Probiotics in nutritional health problems: Probiotics as Nutribiotics26. Role of Immunobiotic Lactic Acid Bacteria as Vaccine Adjuvants27. Probiotics: Current challenges and Health safety considerations28. Probiotics: Current regulatory aspects of probiotics for use in different disease conditions

Dr. Mitesh Kumar Dwivedi has completed PhD from Department of Biochemistry, The M. S. University of Baroda, Vadodara (2013); M.Sc. Microbiology from University of Mysore (2006) and B.Sc. Microbiology from Sardar Patel University (2004). Since 2014, he is serving as Assistant Professor at C. G. Bhakta Institute of Biotechnology, Uka Tarsadia University. He has published 42 research papers in reputed journals and written 5 book chapters. His research interests include exploring the immunological, genetic causes and therapeutics for autoimmune diseases such as Vitiligo, rheumatoid arthritis, thyroidism, etc. and use of probiotics in human health and diseases. N. Amaresan is a microbiologist and Professor at the Saveetha Institute of Basic Medical Sciences, Saveetha University, Chennai. He was previously an Assistant Professor at C.G. Bhakta Institute of Biotechnology, Uka Tarsadia University, Gujarat. He earned his PhD on endophytic plant growth-promoting bacteria from Bharathidasan University, Tamil Nadu. With extensive experience in teaching and research, he has made a number of original contributions across several allied fields of microbiology, principally plant–microbe interactions, bioremediation, and plant pathology. For his discoveries on agriculturally important microorganisms, he has received young scientist awards from the Association of Microbiologists of India and the National Academy of Biological Sciences, along with a visiting scientist fellowship from the National Academy of Sciences, India, to pursue advanced techniques. He has deposited more than 380 bacterial 16S rDNA and fungal ITS rDNA sequences in GenBank (NCBI, EMBL, and DDBJ) and preserved over 150 microbial germplasm accessions in culture collection centers across India. Dr. A. Sankaranarayanan is working as an Assistant Professor in Microbiology, C.G. Bhakta Institute of Biotechnology, Uka Tarsadia University, Gujarat from 2015 onwards. Prior to his present position he served as an Assistant Professor & Head, Department of Microbiology, K.S.R. College of Arts & Science, Tiruchengode, Tamil Nadu from 2002-2015. He has experience in the fields of antimicrobial activity, antibacterial potential of nanoparticles and environmental microbiology. His current research focus is on antibacterial potential of herbal products against multi drug resistant microbial pathogens and pesticide / insecticide degradation by bacteria and fungi in freshwater ecosystem. Dr Helen Kemp completed her PhD in Microbiology at the University of Warwick and the Centre for Applied Microbiology and Research, Salisbury, in 1988. Since 1989, she has worked at the University of Sheffield as a Postdoctoral Research Fellow in the Department of Molecular Biology and Biotechnology and then in the Department of Oncology and Metabolism. She has a long-standing interest in the autoimmune and genetic aspects of the depigmenting disease vitiligo and has international collaborations on projects to profile autoantibody responses against melanocytes in melanoma, vitiligo and alopecia areata. She is also interested in characterizing autoimmune responses against the calcium-sensing receptor in patients with parathyroid autoimmunity. She has published more than 70 research papers and has contributed to books and review articles. She has been on the British Skin Foundation Grant Review Board and served as Section Editor for the British Journal of Dermatology.

"Overall, the book provides a comprehensive review of the role of probiotics in human disease. Additionally, it moves the conversation toward their use in prevention and cure. There are very limited existing textbooks like this on the market, aside from a recently published title, Probiotics for Human Nutrition in Health and Disease, de Souza et al. (Elsevier, 2022), making comparison difficult. I noted grammatical errors and inconsistencies across sections, likely because a different group of researchers authored each chapter. If readers are able to overlook these details, this book proves itself a useful guide to improve the understanding of the present and possible future applications of probiotics. " --© Doody’s Review Service, 2021, Kristen Kimble, MS, RD, LDN, reviewer, expert opinion

• 1. The concept of probiotics, prebiotics, postbiotics, synbiotics, nutribiotics and pharmabiotics2. Food or Pharma: The name does make a difference3. The Role of Probiotics in maintaining immune homeostasis4. Probiotics in the prevention and management of Inflammatory bowel diseases (Crohn’s disease, Ulcerative colitis, Pouchitis)5. Probiotics in the prevention and management of Irritable bowel syndrome and Necrotising enterocolitis6. Probiotics in the prevention and treatment of Diarrhoeal Diseases7. Probiotics in the prevention and treatment of Atopic skin diseases (Atopic Dermatitis; Atopic eczema)8. Probiotics for the treatment of other dermatological conditions (acne, psoriasis, seborrheic dermatitis, wounds, and skin cancer)9. Probiotics in the prevention and management of allergic diseases (Asthma, Allergic Rhinitis)10. Prenatal and Neonatal Probiotic Intake in Pediatric Allergy11. Probiotics and Prebiotics in suppression of Autoimmune diseases (Cystic fibrosis, Rheumatoid arthritis)12. Probiotics and Prebiotics in the prevention and management of  Human cancers (Colon Cancer, Stomach cancer, Breast cancer, Cervix cancer) 13. Probiotics in mitigation of Food allergies and lactose intolerance14. Probiotics in the prevention and management of nosocomial infections15. Role of probiotics in Urological Health16. Role of probiotics in Prevention and treatment of Candida Vaginosis and Bacterial Vaginosis17. Role of Probiotics in Oral Healthcare (Dental Caries; Periodontal Diseases: Gingivitis and periodontitis, Halitosis)18. Role of probiotics in infections with Multidrug-Resistant Organisms (MDROs)19. Probiotics in the prevention and treatment of infections with Helicobacter pylori, Enterohemorrhagic E. coli and Rotavirus20. Role of Probiotics in management of Fungal infections21. Role of probiotics in the prevention and management of diabetics and obesity22. Probiotics in the prevention and management of cardiovascular diseases with focus on dyslipidemia23. Gut brain Axis: Role of probiotics in Neurological and neurodevelopmental disorders including Autism Spectrum Disorder24. Probiotics in prevention and control of food-borne diseases in humans25. Probiotics in nutritional health problems: Probiotics as Nutribiotics26. Role of Immunobiotic Lactic Acid Bacteria as Vaccine Adjuvants27. Probiotics: Current challenges and Health safety considerations28. Probiotics: Current regulatory aspects of probiotics for use in different disease conditions

Dr. Mitesh Kumar Dwivedi has completed PhD from Department of Biochemistry, The M. S. University of Baroda, Vadodara (2013); M.Sc. Microbiology from University of Mysore (2006) and B.Sc. Microbiology from Sardar Patel University (2004). Since 2014, he is serving as Assistant Professor at C. G. Bhakta Institute of Biotechnology, Uka Tarsadia University. He has published 42 research papers in reputed journals and written 5 book chapters. His research interests include exploring the immunological, genetic causes and therapeutics for autoimmune diseases such as Vitiligo, rheumatoid arthritis, thyroidism, etc. and use of probiotics in human health and diseases. N. Amaresan is a microbiologist and Professor at the Saveetha Institute of Basic Medical Sciences, Saveetha University, Chennai. He was previously an Assistant Professor at C.G. Bhakta Institute of Biotechnology, Uka Tarsadia University, Gujarat. He earned his PhD on endophytic plant growth-promoting bacteria from Bharathidasan University, Tamil Nadu. With extensive experience in teaching and research, he has made a number of original contributions across several allied fields of microbiology, principally plant–microbe interactions, bioremediation, and plant pathology. For his discoveries on agriculturally important microorganisms, he has received young scientist awards from the Association of Microbiologists of India and the National Academy of Biological Sciences, along with a visiting scientist fellowship from the National Academy of Sciences, India, to pursue advanced techniques. He has deposited more than 380 bacterial 16S rDNA and fungal ITS rDNA sequences in GenBank (NCBI, EMBL, and DDBJ) and preserved over 150 microbial germplasm accessions in culture collection centers across India. Dr. A. Sankaranarayanan is working as an Assistant Professor in Microbiology, C.G. Bhakta Institute of Biotechnology, Uka Tarsadia University, Gujarat from 2015 onwards. Prior to his present position he served as an Assistant Professor & Head, Department of Microbiology, K.S.R. College of Arts & Science, Tiruchengode, Tamil Nadu from 2002-2015. He has experience in the fields of antimicrobial activity, antibacterial potential of nanoparticles and environmental microbiology. His current research focus is on antibacterial potential of herbal products against multi drug resistant microbial pathogens and pesticide / insecticide degradation by bacteria and fungi in freshwater ecosystem. Dr Helen Kemp completed her PhD in Microbiology at the University of Warwick and the Centre for Applied Microbiology and Research, Salisbury, in 1988. Since 1989, she has worked at the University of Sheffield as a Postdoctoral Research Fellow in the Department of Molecular Biology and Biotechnology and then in the Department of Oncology and Metabolism. She has a long-standing interest in the autoimmune and genetic aspects of the depigmenting disease vitiligo and has international collaborations on projects to profile autoantibody responses against melanocytes in melanoma, vitiligo and alopecia areata. She is also interested in characterizing autoimmune responses against the calcium-sensing receptor in patients with parathyroid autoimmunity. She has published more than 70 research papers and has contributed to books and review articles. She has been on the British Skin Foundation Grant Review Board and served as Section Editor for the British Journal of Dermatology.

"Overall, the book provides a comprehensive review of the role of probiotics in human disease. Additionally, it moves the conversation toward their use in prevention and cure. There are very limited existing textbooks like this on the market, aside from a recently published title, Probiotics for Human Nutrition in Health and Disease, de Souza et al. (Elsevier, 2022), making comparison difficult. I noted grammatical errors and inconsistencies across sections, likely because a different group of researchers authored each chapter. If readers are able to overlook these details, this book proves itself a useful guide to improve the understanding of the present and possible future applications of probiotics. " --© Doody’s Review Service, 2021, Kristen Kimble, MS, RD, LDN, reviewer, expert opinion

• 1. The concept of probiotics, prebiotics, postbiotics, synbiotics, nutribiotics and pharmabiotics2. Food or Pharma: The name does make a difference3. The Role of Probiotics in maintaining immune homeostasis4. Probiotics in the prevention and management of Inflammatory bowel diseases (Crohn’s disease, Ulcerative colitis, Pouchitis)5. Probiotics in the prevention and management of Irritable bowel syndrome and Necrotising enterocolitis6. Probiotics in the prevention and treatment of Diarrhoeal Diseases7. Probiotics in the prevention and treatment of Atopic skin diseases (Atopic Dermatitis; Atopic eczema)8. Probiotics for the treatment of other dermatological conditions (acne, psoriasis, seborrheic dermatitis, wounds, and skin cancer)9. Probiotics in the prevention and management of allergic diseases (Asthma, Allergic Rhinitis)10. Prenatal and Neonatal Probiotic Intake in Pediatric Allergy11. Probiotics and Prebiotics in suppression of Autoimmune diseases (Cystic fibrosis, Rheumatoid arthritis)12. Probiotics and Prebiotics in the prevention and management of  Human cancers (Colon Cancer, Stomach cancer, Breast cancer, Cervix cancer) 13. Probiotics in mitigation of Food allergies and lactose intolerance14. Probiotics in the prevention and management of nosocomial infections15. Role of probiotics in Urological Health16. Role of probiotics in Prevention and treatment of Candida Vaginosis and Bacterial Vaginosis17. Role of Probiotics in Oral Healthcare (Dental Caries; Periodontal Diseases: Gingivitis and periodontitis, Halitosis)18. Role of probiotics in infections with Multidrug-Resistant Organisms (MDROs)19. Probiotics in the prevention and treatment of infections with Helicobacter pylori, Enterohemorrhagic E. coli and Rotavirus20. Role of Probiotics in management of Fungal infections21. Role of probiotics in the prevention and management of diabetics and obesity22. Probiotics in the prevention and management of cardiovascular diseases with focus on dyslipidemia23. Gut brain Axis: Role of probiotics in Neurological and neurodevelopmental disorders including Autism Spectrum Disorder24. Probiotics in prevention and control of food-borne diseases in humans25. Probiotics in nutritional health problems: Probiotics as Nutribiotics26. Role of Immunobiotic Lactic Acid Bacteria as Vaccine Adjuvants27. Probiotics: Current challenges and Health safety considerations28. Probiotics: Current regulatory aspects of probiotics for use in different disease conditions